SAMANTHA WATT: Open Payments
NPI 1851813141 · LITTLE ROCK, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$393 in 14 payments from 9 companies in 2025. Trend: 2023 $548 · 2024 $465 · 2025 $393
Food & beverage: $393
| Company | Payments | Amount |
|---|---|---|
| Boston Scientific Corporation | 1 | $143 |
| SHIELD THERAPEUTICS INC | 4 | $80 |
| Lundbeck LLC | 2 | $34 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $29 |
| Otsuka America Pharmaceutical, Inc. | 1 | $27 |
| Astellas Pharma US Inc | 1 | $22 |
| Novo Nordisk Inc | 1 | $22 |
| VERTEX PHARMACEUTICALS INCORPORATED | 1 | $20 |
| Exact Sciences Corporation | 1 | $17 |
Products named: NA, ACCRUFER, REXULTI, XIFAXAN, Veozah, JOURNAVX, Cologuard Collection Kit.
Industry payments across AR — which companies pay providers there.
